MIRM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Mirum Pharmaceuticals (MIRM) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

MIRM is expected to report earnings to rise 30.27% to -39 cents per share on March 05

Mirum Pharmaceuticals MIRM Stock Earnings Reports

Q4'24

Est.

$-0.39

Q3'24

Beat

by $0.15

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.12

Q4'23

Beat

by $0.24

The last earnings report on November 12 showed earnings per share of -30 cents, beating the estimate of -44 cents. With 95.44K shares outstanding, the current market capitalization sits at 2.21B.

View a ticker or compare two or three

Compare

MIRM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MIRM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MIRM (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

950 Tower Lane

Phone

+1 650 667-4085

Employees

264

Web

https://www.mirumpharma.com